Haemonetics (HAE) Equity Ratio (2010 - 2026)

Haemonetics' Equity Ratio history runs 17 years deep, the most recent figure standing at 0.33 for Q1 2026.

• In Q1 2026, Equity Ratio fell 0.76% year-over-year to 0.33; the TTM figure through Mar 2026 stood at 0.33 (down 0.76% YoY), while the FY2026 annual figure was 0.33, down 0.76% from the prior year.
• Equity Ratio was 0.33 for Q1 2026 at Haemonetics, down from 0.37 in the prior quarter.
• In the past five years, Equity Ratio ranged from a high of 0.44 in Q3 2023 to a low of 0.33 in Q1 2026.
• Historically, Equity Ratio has averaged 0.39 across 5 years, with a median of 0.39 in 2022.
• The sharpest annual moves came in 2022 and 2023: Equity Ratio declined 26.87% in 2022, then climbed 13.68% in 2023.
• A 5-year view of Equity Ratio shows it stood at 0.41 in 2022, then advanced by 3.76% to 0.43 in 2023, then retreated by 16.43% to 0.36 in 2024, then increased by 2.14% to 0.37 in 2025, then decreased by 9.17% to 0.33 in 2026.
• The last three Equity Ratio figures came in at 0.33 (Q1 2026), 0.37 (Q4 2025), and 0.35 (Q3 2025), per Business Quant data.